SAB4200346

Anti-SMAD7 (N-terminal) antibody produced in rabbit

Name: Anti-SMAD7 (N-terminal) antibody produced in rabbit
Brand: SIGMA

~1.0 mg/mL, affinity isolated antibody, suitable for western blot: 2 μg/mL

Synonym(s):

Anti-CRCS3, Anti-MAD homolog 7, Anti-MAD homolog 8, Anti-MADH7, Anti-MADH8, Anti-Mothers against DPP homolog 7, Anti-Mothers against DPP homolog 8, Anti-SMAD

Select a Size

All Photos(2)

About This Item

NACRES:

NA.41

UNSPSC Code:

12352203

Product Name

Anti-SMAD7 (N-terminal) antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, suitable for western blot: 2 μg/mL

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen ~46 kDa

species reactivity

human

concentration

~1.0 mg/mL

technique(s)

indirect immunofluorescence: 1-2 μg/mL using human A549 cells.
western blot: 2-4 μg/mL using whole extracts of HEK-293 cells over-expressing human SMAD7.

UniProt accession no.

O15105

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Application

Anti-SMAD7 (N-terminal) antibody produced in rabbit has been used in immunoblotting and immunofluorescence.

Biochem/physiol Actions

SMAD7 (mothers against decapentaplegic homolog 7) is a modulator of TGFβ (transforming growth factor β) signaling in immune cells which are associated with ulcerative colitis and inflammatory bowel syndrome. It plays a major role in the etiology of CRC (colorectal cancer). In addition, it also acts as a mediator of the negative feedback loop for both the TGFβ and BMP (bone morphogenetic proteins) signaling pathways. It is essential for the remodelling of pharyngeal artery and the enlargement of great vessel. In mouse, homozygous removal of Smad7 causes primarily fourth-related arch artery defects. Silencing of Smad7 in RCD (refractory coeliac disease) biopsy samples can decrease the expression of interleukin-6 and tumour necrosis factor-α. Polymorphism of this gene is associated with colorectal cancer. SMAD7 is an inhibitor of the TGFβ (transforming growth factor beta) /BMP (bone morphogenetic proteins) pathway.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

SMAD7 (mothers against decapentaplegic homolog 7), that binds the E3 ubiquitin ligase Smurf1/2. SMAD7 belongs to the family of inhibitory Smads (I-Smads).

Immunogen

peptide corresponding to the N-terminal region of human SMAD7, conjugated to KLH. The corresponding sequence is identical in monkey and differs by 2 amino acids in mouse and rat.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Not finding the right product?

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

061M4887

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma.

Shan Wei et al.

Cancer science, 112(5), 1865-1877 (2021-02-06)

The histone acetyltransferase MOF (KAT8) is mainly involved in the acetylation of histone H4 at lysine 16 (H4K16) and some non-histone proteins. The MOF expression level is significantly reduced in many cancers, however the biological function of MOF and its

Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.

Fortini BK

PLoS ONE, 9 (2014)

High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.

Sedda S

Immunology, 150, 356-363 (2017)

Intronic polymorphisms of the SMAD7 gene in association with colorectal cancer.

Damavand B

Asian Pacific Journal of Cancer Prevention, 16, 41-44 (2015)

Smad7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling

Yan X and Chen YG

The Biochemical Journal, 434(1), 1-10 (2011)

View All Related Papers